BCYC — Bicycle Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00
- $998.65m
- $502.92m
- $26.98m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -30.6 | -51 | -66.8 | -113 | -181 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 8.46 | 6.59 | 12.6 | 27.2 | 33.5 |
Other Non-Cash Items | |||||
Changes in Working Capital | -7.43 | 25.4 | 38.1 | 0.672 | 76.7 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -28.6 | -17.8 | -14.8 | -86.1 | -60.6 |
Capital Expenditures | -1.55 | -1.2 | -2.03 | -19 | -2.93 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | -1.55 | -1.2 | -2.03 | -19 | -2.93 |
Financing Cash Flow Items | — | -0.573 | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 58.4 | 62.8 | 321 | 6.69 | 250 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 28.7 | 43.9 | 303 | -99.5 | 188 |